Search

Your search keyword '"Castella, Barbara"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Castella, Barbara" Remove constraint Author: "Castella, Barbara"
179 results on '"Castella, Barbara"'

Search Results

1. Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity

2. Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models

4. Supplementary Figures from Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors

5. Data from Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors

6. Supplementary Materials and Methods from Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors

7. Supplementary Figure Legends from Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors

9. Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status

10. Additional file 1 of Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity

12. Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells

13. Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus Acute Lymphoblastic Leukemia study

14. Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study

16. Molecular dynamics of targeting CD38 in multiple myeloma

18. Immunomodulatory and clinical effects of daratumumab in T‐cell acute lymphoblastic leukaemia

21. Additional file 4: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

22. Additional file 2: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

23. Additional file 1: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

24. Additional file 11: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

25. Additional file 7: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

26. Additional file 9: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

27. Additional file 6: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

28. Additional file 8: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

29. Additional file 5: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

30. Additional file 3: of Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

39. ATP-Binding-Cassette A1 Regulates Extracellular Isopentenyl Pyrophosphate Release and Vγ9Vδ2 T-Cell Activation By Dendritic Cells

41. Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

47. The CXCR4 Downstream Signaling Pathways in Chronic Lymphocytic Leukemia: a Target to Reverse Microenvironment Protection

48. Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors

49. Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL)

Catalog

Books, media, physical & digital resources